Lifecore Biomedical Inc
Suletud
Sektor Tarbekaubad (kaitseaktsiad)
4.76 4.39
Ülevaade
Aktsiahinna muutus
24h
Min
4.7
Max
4.81
Soovitused | Osta |
---|---|
12 kuu keskmine prognoos | +67.71 upside |
Turukapital | -5.2M 188M |
---|---|
Eelmine avamishind | 0.37 |
Eelmine sulgemishind | 4.76 |
Uudiste sentiment
By Acuity
50%
50%
37 / 120 Pingereas Consumer defensive
Lifecore Biomedical Inc Graafik
Seotud uudised
Võrdlus sarnastega
Hinnamuutus
Lifecore Biomedical Inc Prognoos
Hinnasiht
By TipRanks
67.71% tõus
12 kuu keskmine prognoos
Keskmine 8 USD 67.71%
Kõrge 8 USD
Madal 8 USD
Põhineb 2 Wall Streeti analüütiku instrumendi Lifecore Biomedical Inc 12 kuu hinnasihil - viimase 3 kuu andmed.
Sentiment
By Acuity
37 / 120 Pingereas Tarbekaubad (kaitseaktsiad)
Uudiste sentiment
Neutral
Volatiilsus
Alla keskmise
Uudismaht (RCV)
Keskmine
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$
Ettevõttest Lifecore Biomedical Inc
Landec Corporation designs, develops, manufactures, and sells differentiated products for food and biomaterials markets. The Company licenses technology applications to partners. Its two operating businesses include Curation Foods, Inc. (Curation Foods) and Lifecore Biomedical, Inc. (Lifecore). Curation Foods is engaged in processing, marketing, and selling of fresh packaged plant-based salads and vegetables. Curation Foods brands include Eat Smart, O Olive Oil & Vinegar, Yucatan & Cabo Fresh Avocado Product, BreatheWay Packaging Technology and Windset. Lifecore is an integrated contract development and manufacturing organization (CDMO) that offers sterile, injectable pharmaceutical products in syringes and vials. Lifecore also manufactures pharmaceutical-grade sodium hyaluronate (HA). Its services include technology development, material component changes, analytical method development and formulation development.